Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: ARS Pharmaceuticals

FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...

CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...

Intranasal Epinephrine to Take Center Stage at 2022 AAAAI Annual Meeting

Intranasal Delivery of Emergency Epinephrine Takes Another Step Toward Realization

Emergency Epinephrine Nasal Spray Takes Final Step Toward Approval in EU

ARS Pharmaceuticals Announces New Patent on ARS-1 (Epinephrine Nasal Spray)

Study: Intranasal Epinephrine Absorbed Faster Than Injection and Even Better with...

ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...

FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray

Follow Us

Your School On Our Map

Put Your School on the Map